Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The unique C-terminal and N-terminal sequences of MT3 on gene expression profiles of MCF-7 cells

ABSTRACT: MCF-7 cells were transfected with various metallothionein gene constructs with contain the insertion or the removal of the unique MT3 C- and N-terminal domains. The goal of this study was to determine how the global gene expression of the unique C- and N- terminal domains of MT3 was correlated to phenotypic properties of the cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE98344 | GEO | 2017/04/29

SECONDARY ACCESSION(S): PRJNA384784

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq for WT and SCID mT3-2D KPC Tumors and mT3-2D cell lines

Project description:To investigate how pancreatic malignant epithelial cells responded to anti-tumor T-cell immune responses in vivo, RNA-seq was used to examine the gene expression profiles of the mT3-2D-GFP cell line and FACS sorted mT3-2D-GFP cancer cells isolated from WT and SCID tumors.

2021-02-26 | GSE165166 | GEO

SCID mT3-2D KPC Tumors and mT3-2D cell lines

Project description:SCID mT3-2D KPC Tumors and mT3-2D cell lines

| PRJNA693458 | ENA

WES for WT and SCID mT3-2D KPC Tumors and mT3-2D cell line

Project description:To determine the influence of in vivo tumor growth and antitumor immune responses on the generation of tumor neoepitopes, we performed whole exome sequencing (WES) on the mT3-2D cell line, WT tumors and SCID tumors

2021-02-26 | GSE165167 | GEO

Camelina sativa cultivar:MT3

Project description:Camelina sativa MT3 Resequencing

| PRJNA535262 | ENA

Mouse PanCancer Immune Panel on WT and SCID mT3-2D KPC Tumors

Project description:To comprehensively assess the immune milieu of WT and SCID mT3-2D tumors, we employed NanoString nCounter immune profiling. The two groups of samples exhibited distinct immune profiles and indicated greater upregulation of immune-related genes in mT3-2D WT tumors than in SCID tumors.

2021-02-26 | GSE165165 | GEO

Achromobacter denitrificans strain:MT3

Project description:Achromobacter denitrificans strain:MT3 Genome sequencing and assembly

| PRJNA359932 | ENA

WES for WT and SCID mT3-2D KPC Tumors and mT3-2D cell line

Project description:WES for WT and SCID mT3-2D KPC Tumors and mT3-2D cell line

| PRJNA693491 | ENA

RNA-seq for WT and SCID mT3-2D KPC Tumors and mT3-2D cell lines

Project description:RNA-seq for WT and SCID mT3-2D KPC Tumors and mT3-2D cell lines

| PRJNA693490 | ENA

Homo sapiens

Project description:The unique C-terminal and N-terminal sequences of MT3 on gene expression profiles of MCF-7 cells

| PRJNA384784 | ENA

RhoBTB1 C-Terminal Binding Proteins

Project description:We identified Rho Related BTB Domain Containing 1 (RhoBTB1) as a key regulator of phosphodiesterase 5 (PDE5) activity, and through PDE5, a regulator of vascular tone. We identified the binding interface for PDE5 on RhoBTB1 by truncating full-length RhoBTB1 into its component domains. Co-immunoprecipitation analyses revealed that the C-terminal half of RhoBTB1 containing its two BTB domains and the C-terminal domain (B1B2C) is the minimal region required for PDE5 recruitment and subsequent proteasomal degradation via the Cullin-3 (CUL3). The C-terminal domain was essential in recruiting PDE5 as constructs lacking this region could not participate in PDE5 binding or proteasomal degradation. We also identified Pro353 and Ser363 as key amino acid residues in the B1B2C region involved in CUL3 binding to RhoBTB1. Mutation of either of these residues exhibited impaired CUL3 binding and PDE5 degradation, although the binding to PDE5 was preserved. Finally, we employed ascorbate peroxidase 2 (APEX2) proximity labeling using a B1B2C-APEX2 fusion protein as bait to capture unknown RhoBTB1 binding partners. Among several B1B2C-binding proteins identified and validated, we focused on SET Domain Containing 2 (SETD2). SETD2 and RhoBTB1 directly interacted, and the level of SETD2 increased in response to pharmacological inhibition of the proteasome or Cullin complex, CUL3 deletion, and RhoBTB1-inhibition with siRNA. This suggests that SETD2 is regulated by the RhoBTB1-CUL3 axis. Future studies will determine if SETD2 plays a role in cardiovascular function.

2023-08-21 | PXD043245 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data